Showing 1 - 9 results of 9 for search 'Aaron D Thome', query time: 0.04s Refine Results
  1. 1
    Fractalkine Signaling Regulates the Inflammatory Response in an α-Synuclein Model of Parkinson Disease.

    Fractalkine Signaling Regulates the Inflammatory Response in an α-Synuclein Model of Parkinson Disease. by Aaron D Thome, David G Standaert, Ashley S Harms

    Published 2015-01-01
    Get full text
    Article
  2. 2
    Targeting of the class II transactivator attenuates inflammation and neurodegeneration in an alpha-synuclein model of Parkinson’s disease

    Targeting of the class II transactivator attenuates inflammation and neurodegeneration in an alpha-synuclein model of Parkinson’s disease by Gregory P. Williams, Aubrey M. Schonhoff, Asta Jurkuvenaite, Aaron D. Thome, David G. Standaert, Ashley S. Harms

    Published 2018-08-01
    Get full text
    Article
  3. 3
    α-Synuclein fibrils recruit peripheral immune cells in the rat brain prior to neurodegeneration

    α-Synuclein fibrils recruit peripheral immune cells in the rat brain prior to neurodegeneration by Ashley S. Harms, Vedad Delic, Aaron D. Thome, Nicole Bryant, Zhiyong Liu, Sidhanth Chandra, Asta Jurkuvenaite, Andrew B. West

    Published 2017-11-01
    Get full text
    Article
  4. 4
    Extracellular Vesicles Derived From Ex Vivo Expanded Regulatory T Cells Modulate In Vitro and In Vivo Inflammation

    Extracellular Vesicles Derived From Ex Vivo Expanded Regulatory T Cells Modulate In Vitro and In Vivo Inflammation by Aaron D. Thome, Jason R. Thonhoff, Weihua Zhao, Alireza Faridar, Jinghong Wang, David R. Beers, Stanley H. Appel

    Published 2022-06-01
    Get full text
    Article
  5. 5
    Serum programmed cell death proteins in amyotrophic lateral sclerosis

    Serum programmed cell death proteins in amyotrophic lateral sclerosis by David R. Beers, Weihua Zhao, Jason R. Thonhoff, Alireza Faridar, Aaron D. Thome, Shixiang Wen, Jinghong Wang, Stanley H. Appel

    Published 2021-03-01
    Get full text
    Article
  6. 6
    Ex vivo expansion of dysfunctional regulatory T lymphocytes restores suppressive function in Parkinson’s disease

    Ex vivo expansion of dysfunctional regulatory T lymphocytes restores suppressive function in Parkinson’s disease by Aaron D. Thome, Farah Atassi, Jinghong Wang, Alireza Faridar, Weihua Zhao, Jason R. Thonhoff, David R. Beers, Eugene C. Lai, Stanley H. Appel

    Published 2021-05-01
    Get full text
    Article
  7. 7
    Functional alterations of myeloid cells during the course of Alzheimer’s disease

    Functional alterations of myeloid cells during the course of Alzheimer’s disease by Aaron D. Thome, Alireza Faridar, David R. Beers, Jason R. Thonhoff, Weihua Zhao, Shixiang Wen, Belen Pascual, Joseph C. Masdeu, Stanley H. Appel

    Published 2018-11-01
    Get full text
    Article
  8. 8
    A phase 1 open-label pilot study of low-dose interleukine-2 immunotherapy in patients with Alzheimer’s disease

    A phase 1 open-label pilot study of low-dose interleukine-2 immunotherapy in patients with Alzheimer’s disease by Alireza Faridar, Abdulmunaim M. Eid, Aaron D. Thome, Weihua Zhao, David R. Beers, Maria B. Pascual, Mohammad O. Nakawah, Gustavo C. Roman, Charles S. Davis, Michael Grundman, Joseph C. Masdeu, Stanley H. Appel

    Published 2023-11-01
    Get full text
    Article
  9. 9
    Ex vivo expanded human regulatory T cells modify neuroinflammation in a preclinical model of Alzheimer’s disease

    Ex vivo expanded human regulatory T cells modify neuroinflammation in a preclinical model of Alzheimer’s disease by Alireza Faridar, Matthew Vasquez, Aaron D. Thome, Zheng Yin, Hui Xuan, Jing Hong Wang, Shixiang Wen, Xuping Li, Jason R. Thonhoff, Weihua Zhao, Hong Zhao, David R. Beers, Stephen T. C. Wong, Joseph C. Masdeu, Stanley H. Appel

    Published 2022-09-01
    Get full text
    Article

Search Tools: